Suppositories Kipferon for children: instructions for use and dosage for different ages. Kipferon candles: instructions for use and reviews Kipferon against influenza

R N000126 / 01

Tradename: "Kipferon®"

Dosage form: Vaginal and rectal suppositories

Composition for one suppository:

active substances:
- immunoglobulin complex preparation (CIP) - 0.2 g
- human interferon alpha-2b, recombinant - 500,000 IU

excipients:
- special purpose fat "SolPro" confectionery
for chocolates and sweets - 0.838 g
- oil solid paraffin P-2 - 0.085 g
- emulsifier "Solid" (T-2) - 0.085 g
- sodium hydrogen phosphate dodecahydrate - 0.055mg
- sodium dihydrogen phosphate dihydrate - 0.018mg
- sodium chloride - 0.110mg
- purified water - 0.012 g

Description:

Suppositories of white, white with a yellowish tinge or light beige, with a characteristic odor, cylindrical shape with a pointed end, homogeneous on a longitudinal cut.

An air rod or funnel-shaped recess is allowed on the cut. Non-uniformity of color in the form of marbling is allowed.

ATX code: L03AX

Pharmacotherapeutic group: MIBP is a cytokine.

pharmachologic effect:

Immunomodulatory;

Antiviral;

Anti-chlamydial.

Pharmacological properties:

Suppositories "KipferonO" is a complex dosage form containing human recombinant interferon-α 2 and a complex immunoglobulin preparation (CIP). Interferon-α 2 is an activator of innate and acquired immunity, has a pronounced antiviral activity, enhances protection against viral, chlamydial, mycoplasma and bacterial infections, has an immunomodulatory effect in the development of immunological reactions, promotes the growth and preservation of normal intestinal and vaginal flora. The biological activity of interferon-α 2 is realized through interaction with the receptor apparatus of immunocompetent and other cells, leading to an increase in the expression of HLA I and HLA II molecules on the surface of all types of cells and regulation of cell cooperation, an increase in the activity of natural killer cells, as well as imparting resistance to intact cells. cytolytic action, proliferation of CD8 T cells. Increases the production of interferon gamma by natural killers. The complex immunoglobulin preparation KIP contains specific and nonspecific immunoglobulins of classes G, M, A. The combination of antiviral, antichlamydial, antibacterial and antitoxic antibodies belonging to different classes of immunoglobulins provides agglutination, neutralization and precipitation of etiotropic pathogenic agents. At the site of application, it stabilizes interferon from secretions of the mucous membranes, normalizes local immunity due to the intake of IgA and IgM with suppositories (replacement effect), increases the activity of locally formed cytokines.

Indications for use:

The drug is used in the complex therapy of diseases accompanied by secondary immunodeficiency conditions:

Acute respiratory diseases, inflammatory diseases of the oropharynx of bacterial and viral etiology in children and adults;

Acute viral (rotavirus) and bacterial (salmonellosis, dysentery, coli infection) intestinal infections, including those with manifestations of intestinal dysbiosis of various severity in children;

Urogenital chlamydia in women (including pregnant women in the II-III trimesters of pregnancy), including with manifestations of vaginal dysbiosis, vulvovaginitis, cervicitis of the uterus, erosion of the cervix.

Contraindications:

Individual intolerance to individual components, pregnancy, I trimester, lactation.

Method of administration and dosage:

"KipferonO" is used rectally and vaginally. The drug is used in combination with conventional means of pathogenetic therapy of infectious diseases, as well as antibiotics when indicated. The method and dosage regimen, as well as the use in complex treatment, is determined by the doctor depending on the diagnosis, severity and severity of the disease.

Acute respiratory diseases, inflammatory diseases of the oropharynx of bacterial and viral etiology: suppositories are administered rectally (mainly after the act of defecation) for children under 1 year old, one suppository per day, for children under 12 years old - 1 suppository twice a day, for adults and children over 12 years old - 1 suppository three times a day. The most effective and appropriate appointment of "Kipferon®" in the acute period of the disease (preferably in the first 3 days). The duration of the course of treatment is determined by the etiology, the form of the severity of the disease, the presence of concomitant complications, pathological conditions and is 5-7 days.

Acute viral (rotavirus) and bacterial (salmonellosis, dysentery, coli-infection) intestinal infections, including with manifestations of intestinal dysbiosis of various severity in children: suppositories are administered rectally (mainly after the act of defecation) to children under 1 year of age, one suppository per day, children under 12 years old - 1 suppository twice a day, adults and children over 12 years old - 1 suppository three times a day. The most effective and appropriate appointment of the drug in the acute period of the disease (preferably in the first 3 days). The duration of the course of treatment is determined by the etiology, the form of the severity of the disease, the presence of concomitant complications, pathological conditions and is 5-7 days.

Urogenital chlamydia in women (including pregnant women duringII- III trimesters of pregnancy), including with manifestations of vaginal dysbiosis, vulvovaginitis, uterine cervicitis, cervical erosion: suppositories are injected deeply intravaginally (before contact with the posterior vaginal fornix and cervix) 1-2 suppositories, depending on the severity of the disease, twice in a day. The course of treatment is on average 10 days; in the presence of cervical erosion, the use of the drug is continued until its epithelialization. If indicated, the course of treatment can be repeated in one month. Treatment should be started in the first days after the end of menstruation. Before the introduction, it is recommended to remove mucus from the mucous membranes of the vagina and cervix.

Precautions:

Overdose:

Cases of drug overdose are not known.

Interaction with other medicinal products:

No adverse effects on other drugs were noted.

Side effects: Not registered.

Release form:

5 suppositories in a blister strip packaging.

2 blisters each with instructions for use in a cardboard box.

Storage conditions:

Store at temperatures from 2 ° C to 8 ° C, out of reach of children.

Shelf life:

Do not use later than the date indicated on the package.

Conditions for dispensing from pharmacies.

Dispensed without a doctor's prescription.

Manufacturer:

LLC "Alfarm", 125212, Russia, Moscow, st. Admiral Makarov, 10, building 1.

Altpharm LLC, 142073, Russia, Moscow region, Domodedovsky district, s. Sudakovo, d / o "Lesnoe".

Address for claims:

LLC "Alfarm", 125212, Russia, Moscow, st. Admiral Makarov, 10, bldg. 1.

Kipferon: instructions for use and reviews

Latin name: Kipferon

ATX code: G02CC; L03AX

Active substance: Interferon Alfa, Human Normal Immunoglobulin

Manufacturer: Alfarm, LLC (Russia)

Description and photo update: 26.08.2019

Kipferon is a drug with immunomodulatory, antiviral, anti-inflammatory, anti-Chlamydial and antibacterial effects.

Release form and composition

Dosage forms - suppositories for vaginal or rectal use (5 pcs. In contoured cell packs, 2 packs in a cardboard box; 10 pcs. In a contoured cell pack, 1 pack in a cardboard box).

Active substances:

  • Human recombinant interferon alpha-2 - 500 thousand IU;
  • Complex immunoglobulin preparation (CIP) - 60 mg.

Auxiliary components: paraffin, fat, T-2 emulsifier.

Pharmacological properties

Pharmacodynamics

Kipferon is a drug containing human recombinant interferon alpha-2 and a complex of immunoglobulins.

The pharmacological characteristics of Kipferon are determined by the properties of its constituent components:

  • Interferon alpha-2: activator of innate / acquired immunity with pronounced antiviral activity, increases resistance to chlamydial, mycoplasma, viral and bacterial infections; due to its immunomodulatory effect during immunological reactions, it promotes the growth and preservation of intestinal and vaginal normal flora. The biological activity of interferon alpha-2 is realized by its interaction with the receptor apparatus of immunocompetent and other cells, leading to an increase in the expression of HLAI and HLAII molecules on the surface of all types of cells, and regulation of cell cooperation, an increase in the activity of natural killer cells, as well as the communication of intact cells with resistance to cytolytic action, proliferation of CD8 T cells. Interferon alpha-2 increases the production of interferon gamma by natural killer cells;
  • KIP (complex immunoglobulin preparation): contains specific and non-specific immunoglobulins of classes A, G and M, (IgA, IgG and IgM). The combination of antiviral, antibacterial, antitoxic and antichlamydia antibodies belonging to different classes of immunoglobulins provides agglutination, neutralization and precipitation of etiotropic pathogenic agents. At the site of application, it stabilizes interferon from secretions of mucous membranes, normalizes local immunity due to the intake of IgA and IgM with suppositories (replacement effect), increases the activity of locally formed cytokines.

Indications for use

  • Frequent inflammatory diseases of the respiratory tract, pneumonia, recurrent bronchitis (including with obstructive syndrome);
  • Viral hepatitis A, B and C in children;
  • Viral and bacterial (coli-infection, dysentery, salmonellosis) intestinal infections, herpes, nonspecific inflammatory diseases in adults and children;
  • Dysbacteriosis of the vagina and intestines of various origins;
  • Urogenital chlamydia in women (including with manifestations of vulvovaginitis, vaginal dysbiosis, cervical erosion, cervicitis) against the background of conventional antibiotic therapy;
  • Preparation for planned gynecological and other operations (in order to prevent infectious complications).

Contraindications

  • Pregnancy;
  • Lactation;
  • Individual intolerance to the components of the drug.

Instructions for the use of Kipferon: method and dosage

Suppositories Kipferon are administered intravaginally (before contact with the posterior fornix of the vagina and the cervix) or rectally, 1-2 pcs. 1-2 times a day.

Kipferon can be used as the only etiopathogenetic treatment (without antibiotics) against the background of conventional basic therapy, including dosed nutritional therapy, oral rehydration and, if necessary, infusion therapy. In a severe course of the disease, it is advisable to include antibacterial agents in the complex of therapy.

The duration of treatment is on average 10 days. With erosion of the cervix, therapy is continued until the epithelialization of the erosion. If necessary, repeat the course.

Before intravaginal administration of the suppository, mucus should be removed from the mucous membrane of the vagina and cervix using a tampon. It is recommended to start treatment in the first days after the end of menstruation.

The use of Kipferon for chlamydial infections:

  • Children: 1 suppository per day for 10 days. In girls with erased clinical forms of chlamydial vulvovaginitis without respiratory chlamydia, chlamydial urinary tract infection and clinical manifestations of the inflammatory process of the uterus and its appendages, treatment is carried out in combination with vaginal and oral eubiotics, in other cases Kipferon is combined with antibiotics and eubiotics;
  • Adults: 2-4 suppositories per day, divided into 2 doses, for 10-14 days. The drug is used in combination with antibiotics, vaginal and oral administration of eubiotics. If, after the end of therapy, infection with chlamydia or clinical signs of chlamydia persist, a second course of treatment is prescribed.

For viral hepatitis A, B and C in children, Kipferon is used rectally. Recommended doses depending on the age of the child:

  • Over 12 years old: 4 suppositories per day;
  • 8-11 years old: 3 suppositories per day;
  • Up to 7 years: 500 thousand IU / kg in 2 applications, but not more than 2 suppositories per day.

The duration of treatment in the acute course of the disease is 14 days. The first 7 days, the drug should be used daily, then 2 times a week. With a protracted course of hepatitis, the duration of treatment can be increased to 3-4 weeks.

  • Adults: 2-4 suppositories per day for 10-14 days, if necessary, repeat the course of treatment;
  • Children: 1 suppository 1 time per day for 10 days.

In case of concomitant bacterial infection, antibiotics are additionally prescribed. For women and adolescent girls, it is recommended to start treatment in the first days after the end of menstruation.

With frequent inflammatory diseases of the respiratory tract, pneumonia and recurrent bronchitis in children, Kipferon is used rectally 1 suppository 2 times a day during the first 5 days of treatment, during the next 3 weeks - 2 times a week. If necessary, the drug can be used as part of basic antibacterial therapy.

For intestinal infections, Kipferon is prescribed for children to be used rectally. The suppository should be administered after a natural act of defecation or a cleansing enema. Recommended doses depending on the age of the child:

  • Up to 12 years: in a single dose of 50 thousand IU / kg, but not more than 1 million IU (2 suppositories) per day;
  • Over 12 years: up to 2 million IU (4 suppositories) per day.

In preparation for planned gynecological and other operations, Kipferon is applied rectally 1 suppository 2 times a day (with an interval of 12 hours) for 3-5 days before the operation, during and in the postoperative period. The general course of preventive treatment is 10-15 days.

Side effects

Not identified.

Overdose

Cases of Kipferon overdose are unknown.

special instructions

Before use, you should consult your doctor.

Influence on the ability to drive vehicles and complex mechanisms

Application during pregnancy and lactation

It is contraindicated to use Kipferon during pregnancy and lactation.

Childhood use

In pediatric practice, it is allowed to prescribe Kipferon for children from the first days of life according to indications according to the dosage regimen.

Drug interactions

Kipferon can be used simultaneously with antibacterial drugs and eubiotics.

There is no information on interactions with other medicinal products.

Analogs

Kipferon's analogs are: Altevir, Reaferon-EC-Lipint, Reaferon-EC, Viferon.

Terms and conditions of storage

Store at 2-8 ° C in a place protected from light and moisture.

Expiration date - 1 year.

Kipferon has a pronounced antiviral, antibacterial and antichlamydial activity, exhibits immunomodulatory and anti-inflammatory properties. The complex composition and method of application of the drug determine a number of therapeutic effects: the local and general resistance of the body increases, the pathogen is eliminated and defense mechanisms are activated in the places of penetration of pathogens, the manifestations of viral and microbial intoxication are reduced, with erosion of the cervix, stimulation of reparative processes in its tissues is provided. Kipferon® prevents the deepening of the disturbed balance of autoflora (dysbiosis) and the excessive growth of opportunistic microorganisms in diseases.

Indications for the use of the drug Kipferon

Urogenital chlamydia in women, incl. against the background of vaginal dysbiosis, vulvovaginitis, cervicitis, cervical erosion (in combination with conventional antibiotic therapy.

Contraindications to the use of the drug Kipferon

Hypersensitivity to the components contained in the suppository.

Application of the drug Kipferon

Rectally, intravaginally (before contact with the posterior vaginal fornix and cervix). 1-2 supp. (depending on the severity of the disease), 2 times a day. The course of treatment is, on average, 10 days; in the presence of erosion of the cervix, the application is continued until its epithelialization. If indicated, the course of treatment can be repeated. Treatment should be started in the first days after the end of menstruation. Before the introduction, it is recommended to remove mucus from the mucous membranes of the vagina and cervix.
Prescribing regimens for Kipferon®, suppositories
Chlamydial infections
Children - 1 supp. 1 time per day for 10 days. In girls with erased clinical forms of chlamydial vulvovaginitis and without clinical manifestations of the inflammatory process of the uterus and its appendages, chlamydial urinary tract infection, respiratory chlamydia, treatment is carried out only against the background of vaginal and oral administration of eubiotics, in other cases, treatment of chlamydia in children with Kipferon® is combined with antibiotics. and eubiotics.
Adults - in a daily dose of 1-2 million IU (2-4 supp.) In 2 doses, the course of treatment is 10-14 days; additionally, antibiotic therapy is carried out and eubiotics are prescribed vaginally and orally. If, after treatment, clinical signs of chlamydia or infection with chlamydia persist, a second course of Kipferon® therapy is performed.
For viral hepatitis B, C and A in children
Rectally. For children under 7 years old, Kipferon® is prescribed in a single dose of 50,000 IU / kg of body weight in 2 doses, but not more than 1 million IU / day (2 supp.); 8-11 years old - 1.5 million IU / day (3 supp.); over 12 years old - 2 million IU / day (4 supp.). The duration of the course of treatment for the acute course of viral hepatitis is 14 days. The first 7 days the drug is used daily, then 2 times a week. With a protracted course of the disease, the duration of the course reaches 3-4 weeks.
With frequent inflammatory diseases of the respiratory tract, recurrent bronchitis (including with obstructive syndrome), pneumonia in children
Rectally. In a daily dose of 1 million IU (2 supp.) In 2 doses daily for the first 5 days, then 2 times a week for 3 weeks. It can be used as monotherapy or in complex treatment, against the background of basic antibiotic therapy.
With genital herpes
Adults 1-2 million IU (2-4 supp.) For 10-14 days; a second course of treatment is possible; children - in a daily dose of 500,000 IU (1 supp.) in 1 reception, the course of treatment is 10 days.
Antibiotic therapy for genital herpes is carried out only if there is a concomitant bacterial infection. In women and adolescent girls, drug treatment is recommended to begin in the first days after the end of menstruation. Before vaginal administration, it is advisable to remove mucus with a swab from the mucous membranes of the vagina and cervix.
With intestinal infections in children
Rectally (after a cleansing enema or bowel movement). Children under 12 years old - in an average single dose of 50,000 IU / kg of body weight, but not more than 1 million IU / day (2 supp.), Over 12 years old - no more than 2 million IU (4 supp.). It is most advisable to use the drug in the first 3 days of the disease, i.e. in the acute period. The course of treatment for moderate viral diarrhea is 3-5 days; severe form - 7 days.
Kipferon® may be the only etiopathogenetic treatment (without antibacterial drugs) against the background of generally accepted basic therapy (oral rehydration, dosed nutritional therapy, if necessary, infusion therapy). In severe forms, it is advisable to include antibiotics in the complex of therapy.
In preparation for planned gynecological and other operations in order to prevent infectious complications
Rectally. Kipferon® is used in a daily dose of 1 million IU (2 supp.), In 2 doses, 3-5 days before and during the operation, as well as in the postoperative period. The course of treatment is 10-15 days. The interval between doses is 12 hours.

Side effects of the drug Kipferon

The drug is considered to be low-allergenic, however, the content of a large amount of protein in the suppository can cause an allergic reaction in children.

Drug interactions Kipferon

No data.

List of pharmacies where you can buy Kipferon:

  • St. Petersburg
Kipferon

ATX

L03AX Other immunostimulants

Pharmacological group

Interferons in combinations

pharmachologic effect

Pharmacological action - antiviral, anti-inflammatory, immunomodulatory, antibacterial, anti-Chlamydial. The drug combines the anti-Chlamydial effect of specific antibodies contained in the instrumentation and the antibacterial, antiviral, anti-inflammatory and immunomodulatory effects of recombinant interferon alfa-2. The effect is manifested both in the intracellular and in the extracellular environment of the body due to the direct action on the causative agents of the disease and stimulation of the mechanisms of local and general immunity. The increased protein content in this dosage form provides greater stability of interferon in the presence of aggressive factors of mucosal secretions and secretions in the foci of skin and mucous membranes.

Method of administration and dosage

Rectally, intravaginally (before contact with the posterior vaginal fornix and cervix). 1–2 supp. (depending on the severity of the disease), 2 times a day. The course of treatment is, on average, 10 days; in the presence of erosion of the cervix, the application is continued until its epithelialization. According to indications, the course of treatment can be repeated. Treatment should be started in the first days after the end of menstruation. Before the introduction, it is recommended to remove mucus from the mucous membranes of the vagina and cervix. Schemes of administration of the drug Kipferon®, suppositories Chlamydial infections For children - 1 supp. 1 time per day for 10 days. In girls with erased clinical forms of chlamydial vulvovaginitis and without clinical manifestations of the inflammatory process of the uterus and its appendages, chlamydial urinary tract infection, respiratory chlamydia, treatment is carried out only against the background of vaginal and oral administration of eubiotics, in other cases, the treatment of chlamydia in children with Kipferon® is combined with antibiotics and eubiotics. Adults - in a daily dose of 1-2 million IU (2-4 supp.) in 2 doses, the course of treatment is 10-14 days; additionally, antibiotic therapy is carried out and eubiotics are prescribed vaginally and orally. If, after treatment, clinical signs of chlamydia or infection with chlamydia persist, a second course of therapy with Kipferon® is carried out. For viral hepatitis B, C and A in children Rectal. For children under 7 years old, Kipferon® is prescribed in a single dose of 50,000 IU / kg of body weight in 2 doses, but not more than 1 million IU / day (2 supp.); 8-11 years - 1.5 million IU / day (3 supp.); over 12 years old - 2 million IU / day (4 supp.). The duration of the course of treatment for the acute course of viral hepatitis is 14 days. The first 7 days the drug is used daily, then 2 times a week. With a protracted course of the disease, the duration of the course reaches 3-4 weeks. With frequent inflammatory diseases of the respiratory tract, recurrent bronchitis (including obstructive syndrome), pneumonia in children Rectal. In a daily dose of 1 million IU (2 supp.) In 2 doses daily for the first 5 days, then 2 times a week for 3 weeks. Can be used as monotherapy or in complex treatment, against the background of basic antibiotic therapy. For genital herpes Adults 1-2 million IU (2-4 supp.) For 10-14 days; a second course of treatment is possible; children - in a daily dose of 500,000 IU (1 supp.) in 1 reception, the course of treatment is 10 days. Antibiotic therapy for genital herpes is carried out only in the presence of concomitant bacterial infection. In women and adolescent girls, it is recommended to start treatment with the drug in the first days after the end of menstruation. Before vaginal administration, it is advisable to remove mucus with a swab from the mucous membranes of the vagina and cervix. In case of intestinal infections in children Rectally (after a cleansing enema or an act of defecation). Children under 12 years old - in an average single dose of 50,000 IU / kg of body weight, but not more than 1 million IU / day (2 supp.), Over 12 years old - no more than 2 million IU (4 supp.). It is most advisable to use the drug in the first 3 days of the disease in the acute period. The course of treatment for moderate viral diarrhea is 3-5 days; Severe form - 7 days In severe forms, it is advisable to include antibiotics in the complex of therapy. In preparation for planned gynecological and other operations in order to prevent infectious complications Rectal. Kipferon® is used in a daily dose of 1 million IU (2 supp.), In 2 doses, 3-5 days before and during the operation, as well as in the postoperative period. The course of treatment is 10-15 days. The interval between doses is 12 hours.

Storage conditions

At a temperature of 2-8 ° C. Keep out of the reach of children.

Shelf life

1 year. Do not use after the expiration date indicated on the package. 2000-2017. Register of medicines of Russia

Composition and form of release

Suppositories 1 suppository interferon human recombinant alpha-2 not less than 500000 ME dry complex immunoglobulin preparation (KPI) 60 mg auxiliary substances: fat; paraffin; emulsifier T-2 in a contour acheikova package 10 pcs .; in a pack of cardboard 1 packing.

Indications

Urogenital chlamydia (treatment) in women (including with manifestations of vaginal dysbiosis, vulvovaginitis, cervicitis, cervical erosion) against the background of conventional antibiotic therapy. Nonspecific inflammatory diseases, herpes, viral (retroviral) and bacterial (dysentery, salmonellosis, collie infection) intestinal infections in adults and children; frequent inflammatory diseases of the respiratory tract, recurrent bronchitis, pneumonia; dysbiosis of the vagina and intestines of various origins; viral hepatitis B, C and A in children; in preparation for planned gynecological and other operations (for the prevention of infectious complications.)

Contraindications

Not installed.

Characteristic

A combination of recombinant human interferon alpha-2 and a complex immunobiological preparation (CIP) containing immunoglobulins of the main three classes G, A, M.

Kipferon is a medication in the form of a suppository, which has an antiherpetic effect, improves immunity and fights viruses. It can be used as an independent medicine and prescribed in a complex of therapeutic measures. The composition contains active components - interferon alpha and plasma protein. On the pharmaceutical market, you can pick up an analogue of Kipferon candles.

Application features

The drug under the trade name Kipferon is intended for administration by the rectal / vaginal method. One package contains 10 suppositories. The list of indications for use is wide and includes the following categories:

  • diseases of the mouth and pharynx of an inflammatory nature of viral and bacterial etiology;
  • respiratory diseases in acute form;
  • urogenital chlamydia, accompanied by erosion, vaginal dysbiosis, vulvovaginitis, cervicitis;
  • intestinal infections in an acute form of a viral and bacterial nature;
  • violation of intestinal microflora in childhood.

The medication is approved for the treatment of children with hepatitis, as well as patients before surgery.

Often, doctors and patients use Kipferon substitutes. In the treatment of children, the most accessible and effective are Genferon and Genferon Light, as well as Viferon suppositories. For the administration of drugs, the rectal method is indicated. Suspensions, powders and tablets can also be used. The leading positions are occupied by Immunal, Anaferon, Bronchomunal, Ergoferon, Derinat, Ingaron, Irs-19. These immunomodulating and antiviral agents should be prescribed only by the attending physician, they have different dosages and methods of administration.

In the treatment of adult patients, Kipferon can be replaced with immunomodulatory medications with the trade names Oscillococcinum, Trekrezan, Isoprinosin, Polyoxidonium, Likopid. Most of these drugs are prohibited for the treatment of young children.

In the case of the treatment of diseases of the female genital area, the best analogue is Tantum Rose. This is a solution and powder for the preparation of a suspension, which are administered by the vaginal method. It has a powerful anti-inflammatory effect.

Review of analogues

The only complete analogue of Kipferon is Tantum Rose. Other drugs contain a similar component, interferon, but are incomplete substitutes.

Name Manufacturer Active components Release form Mode of application Appointment
During pregnancy In childhood
Giaferon Russia Interferon, sodium hyaluronate suppositories Vaginal, rectal Not studied no
Viferon Russia interferon Ointment, gel, candles rectally shown allowed
Genferon Light Russia Interferon, taurine suppositories Vaginally, rectally After the 1st trimester Shown
Wagiferon Russia Fluconazole, metronidazole, interferon alfa-2b Suppository form vaginally It is impossible Forbidden under 18
Gerpferon Belarus
Genferon Russia Taurine, benzocaine, interferon suppositories Vaginally, rectally In the second and third trimester according to indications allowed
Tantum Rose Italy Benzydamine hydrochloride Powder for diluting the solution Vaginal insertion Allowed Forbidden under 12 years old.

Any pharmacy has on sale the presented analogs, but their use requires a doctor's prescription and the development of a therapeutic regimen.

Cheap substitutes for Kipferon

The original drug may be cheaper or more expensive than its counterpart. Not all patients are ready to buy a drug at a high price and choose a cheap substitute. When choosing, it is worth considering the age of the patient, his condition and disease. Only a doctor can select a medication with accuracy and develop a treatment.

Kipferon candles have the following cheaper analogs:

  • Derinat - 400 - 500 rubles;
  • Viferon - 200-300 rubles;
  • Bronchomunal - 500-600 rubles;
  • Genferon - 250-350 rubles.

When replacing the original with an analogue, keep in mind that most substitutes are less effective. The content of interferon is reduced in them and there is no second active substance, as in Kipferon.

Kipferon suppositories for the treatment of children can be replaced with a cheaper analogue Viferon. It is an antiviral drug prescribed for infectious and inflammatory diseases, viral hepatitis and acute respiratory viruses. It can be used in the treatment of newborn babies and when the baby is premature and has been diagnosed with an intrauterine infection.

To combat the problems of the genitourinary system in adult patients, including HPV (papilloma), the vaginal / rectal suppositories Genferon or its lighter form with the addition of Light are prescribed.

An analogue of Gerpferon is well suited to suppress the activity of herpesvirus infection.

Inflammatory processes and viruses in the genitourinary system in women are allowed to be treated with Viferon.

During colds, it is optimal to replace Kipferon with Giaferon.

Advantages and disadvantages

Kipferon suppositories, according to the instructions for use, have an advantage - its composition contains human recombinant interferon. This substance is responsible for the normal functioning of the human immune system. The medicine has a wide range of uses. It affects specific enzymes, which allows you to suppress the virus and stop its spread in the cells of the human body. The drug has persistent antibacterial properties, inhibiting the activity of pathogenic bacteria.

The use of Kipferon suppository allows you to relieve inflammation, eliminate infection, and increase the defenses of the immune system. Each consumer review is a confirmation of the effectiveness of the drug.

The main disadvantage is the high cost.

Contraindications and side effects

Kipferon candles, according to the instructions for use, unlike their counterparts, has no contraindications to the appointment. The only exception is individual intolerance to the active or auxiliary components of the drug.

During clinical trials and open sales, no serious side effects have been identified. But in people with protein intolerance, the Kipferon candle can cause allergies in the form of a small rash on the skin, redness or itching.

The following negative reactions can also be observed:

  • a symptomatic picture that resembles a flu infection - muscle pain, migraine, aching bones, fever;
  • Exacerbation of chronic viruses;
  • Feeling of a foreign object in the rectum;
  • Burning and itching in the vagina.

The instruction states that these phenomena are not dangerous and do not require cancellation or replacement with a more expensive or cheaper analogue.

The use of Kipferon helps to get rid of a large number of serious diseases. If there are negative reactions to the drug or its price seems too high, the doctor will select a substitute with a similar effect and composition. But when buying an analogue, it is worth remembering that the Kipferon candle has a more powerful effect than another drug. It is worth considering the decision well, perhaps by saving a ruble on the original medication, you will lose more due to long-term treatment.

Loading ...Loading ...